Spantech
Pressure Swing Adsorption Oxygen Plants
CURRENT IMPACT
As on Feb 2023
2
telehealth centres established
50+
PSA oxygen plants commissioned
Geographical Focus
- PAN India
Potential Impact
- Reach
500,000
lives
Rajendra Tahiliani, Spantech Engineers Pvt Ltd
Our partnership with SAMRIDH has been invaluable in addressing the urgent need for reliable and sustainable oxygen supply in hospitals and COVID centers. With SAMRIDH’s support, we were able to rapidly scale our operations, strengthen our manufacturing capabilities and ensure availability of life-saving oxygen in crucial moments. By working together, we’ve been able to contribute to the resilience of India’s healthcare infrastructure and make a lasting impact in improving access to essential medical resources.
Samridh support
SAMRIDH provided milestone-based funding to Spantech, supporting operational expenses and ensuring sustained access to oxygen supply in Indian healthcare facilities, particularly in Maharashtra and Telangana. Through the partnership, Spantech successfully installed 53 Pressure Swing Adsorption (PSA) oxygen plants in government hospitals and COVID centers, including 13 in Thane and Nashik areas. Leveraging PSA technology with Zeolite Molecular Sieves (ZMS), these plants generate oxygen by separating nitrogen from the air. Spantech also scaled up its manufacturing capacity from 25-30 to 40 units per month, meeting rising demand. This initiative bolstered oxygen availability in critical healthcare settings, fortifying India’s healthcare infrastructure during challenging times. SAMRIDH’s support also included a partial risk guarantee in the form of cash collateral, unlocking 3x additional funding in debt and grants, amplifying the impact.
700
Tonnes to 2,800 the increase in India’s daily medical oxygen demand from pre-pandemic levels to the first COVID wave. [1]
5000
Tones was the demand for medical oxygen during the second COVID wave. [2]
7,200
MTPD Was India’s oxygen capacity, but it failed to reach rural areas, as urban-centric distribution and inadequate networks led to shortages and tragic losses. [3]
The COVID-19 pandemic has opened our eyes towards a severe problem of oxygen supply during emergencies. A staggering number of deaths were due to lack of oxygen supply rather than the virus itself. Currently efforts are being made in this space to increase the supply and storage of medical oxygen in India. Both the government and private players are working towards creating new technologies and respiratory plants across the country to increase production of medical oxygen in India.
[1]Desk, India Today Web. 2021. “Explained: Why India is facing oxygen shortage during 2nd Covid wave.” India Today, April 22, 2021.
[2]Ibid.
[3]Ibid.
Spantech Engineers has equipped targeted public health facilities across India with new Pressure Swing Absorption (PSA) Oxygen units to provide critical care by ensuring continuous oxygen supply. Spantech has the technological expertise to develop the entire plant indigenously with import of only necessary component of Zeolite Molecular Sieves (ZMS). The plants are directly installed at the site. The key raw material for import of ZMS takes about 30 days during which the fabrication is readied at the installation site. Post ZMS arrival, it takes about 4-5 days for commissioning.
Key Stakeholders
